XML 28 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Net Income (Loss) Attributable to Shareholders of Crawford & Company per Common Share
9 Months Ended
Sep. 30, 2016
Earnings Per Share [Abstract]  
Net Income (Loss) Attributable to Shareholders of Crawford & Company per Common Share
Net Income (Loss) Attributable to Shareholders of Crawford & Company per Common Share
The Company computes earnings per share of its non-voting Class A Common Stock ("CRD-A") and voting Class B Common Stock ("CRD-B") using the two-class method, which allocates the undistributed earnings in each period to each class on a proportionate basis. The Company's Board of Directors has the right, but not the obligation, to declare higher dividends on the CRD-A shares than on the CRD-B shares, subject to certain limitations. In periods when the dividend is the same for CRD-A and CRD-B or when no dividends are declared or paid to either class, the two-class method generally will yield the same earnings per share for CRD-A and CRD-B. For all three quarters of 2016 and 2015 the Board of Directors declared a higher dividend on CRD-A than on CRD-B.
The computations of basic net income (loss) attributable to shareholders of Crawford & Company per common share were as follows:
 
Three months ended
 
Nine months ended
 
September 30,
2016
 
September 30,
2015
 
September 30,
2016
 
September 30,
2015
(in thousands, except per share amounts)
CRD-A
CRD-B
 
CRD-A
CRD-B
 
CRD-A
CRD-B
 
CRD-A
CRD-B
Earnings (loss) per share - basic:
 
 
 
 
 
 
 
 
 
 
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
Allocation of undistributed earnings (loss)
$
4,196

$
3,350

 
$
(2,360
)
$
(1,891
)
 
$
10,003

$
8,037

 
$
(2,198
)
$
(1,770
)
Dividends paid
2,166

1,234

 
2,160

1,234

 
6,459

3,703

 
6,447

3,704

Net income (loss) attributable to common shareholders, basic
$
6,362

$
4,584

 
$
(200
)
$
(657
)
 
$
16,462

$
11,740

 
$
4,249

$
1,934






 




 




 




Denominator:




 




 




 




Weighted-average common shares outstanding, basic
30,922

24,690

 
30,807

24,690

 
30,731

24,690

 
30,668

24,690

Earnings (loss) per share - basic
$
0.21

$
0.19

 
$
(0.01
)
$
(0.03
)
 
$
0.54

$
0.48

 
$
0.14

$
0.08


The computations of diluted net income (loss) attributable to shareholders of Crawford & Company per common share were as follows:
 
Three months ended
 
Nine months ended
 
September 30,
2016
 
September 30,
2015
 
September 30,
2016
 
September 30,
2015
(in thousands, except per share amounts)
CRD-A
CRD-B
 
CRD-A
CRD-B
 
CRD-A
CRD-B
 
CRD-A
CRD-B
Earnings (loss) per share - diluted:
 
 
 
 
 
 
 
 
 
 
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
Allocation of undistributed earnings (loss)
$
4,240

$
3,306

 
$
(2,360
)
$
(1,891
)
 
$
10,071

$
7,969

 
$
(2,214
)
$
(1,754
)
Dividends paid
2,166

1,234

 
2,160

1,234

 
6,459

3,703

 
6,447

3,704

Net income (loss) attributable to common shareholders, diluted
$
6,406

$
4,540

 
$
(200
)
$
(657
)
 
$
16,530

$
11,672

 
$
4,233

$
1,950

 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding, basic
30,922

24,690

 
30,807

24,690

 
30,731

24,690

 
30,668

24,690

Weighted-average effect of dilutive securities
743


 


 
469


 
488


Weighted-average common shares outstanding, diluted
31,665

24,690

 
30,807

24,690

 
31,200

24,690

 
31,156

24,690

Earnings (loss) per share - diluted
$
0.20

$
0.18

 
$
(0.01
)
$
(0.03
)
 
$
0.53

$
0.47

 
$
0.14

$
0.08


Listed below are the shares excluded from the denominator in the above computation of diluted earnings (loss) per share for CRD-A because their inclusion would have been antidilutive:
 
Three months ended
 
Nine months ended
(in thousands)
September 30,
2016
 
September 30,
2015
 
September 30,
2016
 
September 30,
2015
Shares underlying stock options excluded due to the options' respective exercise prices being greater than the average stock price during the period
50

 
15

 
70

 
32

Performance stock grants excluded because performance conditions have not been met (1)
895

 
1,819

 
895

 
1,969

________________________________________________
(1) 
Compensation cost is recognized for these performance stock grants based on expected achievement rates; however, no consideration is given to these performance stock grants when calculating earnings per share until the performance measurements have been achieved. The performance measurements for approximately 529,000 outstanding performance stock grants as of September 30, 2016 are expected to be achieved by December 31, 2016.
The following table details shares issued during the three months and nine months ended September 30, 2016 and September 30, 2015. These shares are included from their dates of issuance in the weighted-average common shares used to compute basic earnings per share for CRD-A in the table above. There were no shares of CRD-B issued during any of these periods.
 
Three months ended
 
Nine months ended
(in thousands)
September 30,
2016
 
September 30,
2015
 
September 30,
2016
 
September 30,
2015
CRD-A issued under non-employee director stock plan
2

 
4

 
121

 
59

CRD-A issued under the Employee Stock Purchase Plan
119

 
107

 
119

 
107

CRD-A issued under the U.K. ShareSave Scheme
10

 
5

 
151

 
101

CRD-A issued under the International Employee Stock Purchase Plan
7

 
7

 
7

 
7

CRD-A issued under the Executive Stock Bonus Plan
13

 
20

 
17

 
94


The Company's share repurchase authorization, approved in August 2014, provides the Company with the ability to repurchase up to 2,000,000 shares of CRD-A or CRD-B (or both) through July 2017 (the "2014 Repurchase Authorization"). Under the 2014 Repurchase Authorization, repurchases may be made in open market or privately negotiated transactions at such times and for such prices as management deems appropriate, subject to applicable contractual and regulatory restrictions.
During the three months and nine months ended September 30, 2016, the Company did not repurchase any shares. During the three months and nine months ended September 30, 2015, the Company repurchased 500,000 and 517,700 shares of CRD-A, respectively, at an average cost of $6.62 and $6.66 per share, respectively. The Company did not repurchase any shares of CRD-B during any of these periods.